Saeid Ghavami
Saeid Ghavami
Associate Professor, Department of Human Anatomy and Cell Science, University of Manitoba, Canada
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2021
Autophagy and apoptosis dysfunction in neurodegenerative disorders
S Ghavami, S Shojaei, B Yeganeh, SR Ande, JR Jangamreddy, ...
Progress in neurobiology 112, 24-49, 2014
Apoptosis and cancer: mutations within caspase genes
S Ghavami, M Hashemi, SR Ande, B Yeganeh, W Xiao, M Eshraghi, ...
Journal of medical genetics 46 (8), 497-510, 2009
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
S Ghavami, I Rashedi, BM Dattilo, M Eshraghi, WJ Chazin, M Hashemi, ...
Journal of Leucocyte Biology 83 (6), 1484-1492, 2008
Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells
C Gong, C Bauvy, G Tonelli, W Yue, C Delomenie, V Nicolas, Y Zhu, ...
Oncogene 32 (18), 2261-2272, 2013
Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response
S Hombach-Klonisch, M Mehrpour, S Shojaei, C Harlos, M Pitz, A Hamai, ...
Pharmacology & therapeutics, 2018
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3
S Ghavami, M Eshragi, SR Ande, WJ Chazin, T Klonisch, AJ Halayko, ...
Cell research 20 (3), 314-331, 2010
Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions
S Ghavami, C Kerkhoff, M Los, M Hashemi, C Sorg, F Karami-Tehrani
Journal of Leukocyte Biology 76 (1), 169-175, 2004
Cellular commitment in the developing cerebellum
H Marzban, MR Del Bigio, J Alizadeh, S Ghavami, RM Zachariah, ...
Frontiers in cellular neuroscience 8, 450, 2015
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
S Drożdżal, J Rosik, K Lechowicz, F Machaj, B Szostak, J Przybyciński, ...
Drug Resistance Updates 59, 100794, 2021
Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directions
S Gholizadeh, MS Draz, M Zarghooni, A Sanati-Nezhad, S Ghavami, ...
Biosensors and Bioelectronics 91, 588-605, 2017
Brevinin‐2R1 semi‐selectively kills cancer cells by a distinct mechanism, which involves the lysosomal‐mitochondrial death pathway
S Ghavami, A Asoodeh, T Klonisch, AJ Halayko, K Kadkhoda, TJ Kroczak, ...
Journal of cellular and molecular medicine 12 (3), 1005-1022, 2008
Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts
S Ghavami, RH Cunnington, S Gupta, B Yeganeh, KL Filomeno, ...
Cell death & disease 6 (3), e1696-e1696, 2015
The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections
P Mehrbod, SR Ande, J Alizadeh, S Rahimizadeh, A Shariati, H Malek, ...
Virulence 10 (1), 376-413, 2019
Apoptosis in liver diseases-detection and therapeutic applications
S Ghavami, M Hashemi, K Kadkhoda, SM Alavian, GH Bay, MJ Los
Medical science monitor 11 (11), RA337-RA345, 2005
Betulin and its derivatives as novel compounds with different pharmacological effects
S Amiri, S Dastghaib, M Ahmadi, P Mehrbod, F Khadem, H Behrooj, ...
Biotechnology Advances, 2020
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
B Yeganeh, E Wiechec, SR Ande, P Sharma, AR Moghadam, M Post, ...
Pharmacology & therapeutics 143 (1), 87-110, 2014
The urgent need for integrated science to fight COVID-19 pandemic and beyond
N Moradian, HD Ochs, C Sedikies, MR Hamblin, CA Camargo, ...
Journal of translational medicine 18 (1), 1-7, 2020
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells
M Hashemi, S Ghavami, M Eshraghi, EP Booy, M Los
European journal of pharmacology 557 (1), 9-19, 2007
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
S Drożdżal, J Rosik, K Lechowicz, F Machaj, K Kotfis, S Ghavami, MJ Łos
Drug resistance updates 53, 100719, 2020
The system can't perform the operation now. Try again later.
Articles 1–20